2-chloro-7-nitro-quinoxaline - CAS 55686-94-7
Catalog: |
BB029130 |
Product Name: |
2-chloro-7-nitro-quinoxaline |
CAS: |
55686-94-7 |
Synonyms: |
2-chloro-7-nitroquinoxaline; 2-chloro-7-nitroquinoxaline |
IUPAC Name: | 2-chloro-7-nitroquinoxaline |
Description: | 2-chloro-7-nitro-quinoxaline (CAS# 55686-94-7) is a useful research chemical. |
Molecular Weight: | 209.589 |
Molecular Formula: | C8H4ClN3O2 |
Canonical SMILES: | C1=CC2=NC=C(N=C2C=C1[N+](=O)[O-])Cl |
InChI: | InChI=1S/C8H4ClN3O2/c9-8-4-10-6-2-1-5(12(13)14)3-7(6)11-8/h1-4H |
InChI Key: | DCWHGXURAAYUEC-UHFFFAOYSA-N |
MDL: | MFCD00033669 |
LogP: | 2.71460 |
GHS Hazard Statement: | H301 (97.44%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P310, P302+P352, P304+P340, P305+P351+P338, P310, P312, P321, P330, P332+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
US-2021171535-A1 | Tricyclic heterocycles as fgfr inhibitors | 20191204 |
WO-2021113479-A1 | Tricyclic heterocycles as fgfr inhibitors | 20191204 |
KR-20190137013-A | Heterocyclic Derivatives and Use Thereof | 20180531 |
KR-102070265-B1 | Novel [1,2,4]Triazolo[4,3-a]quinoxaline derivatives, preparation method therof, and pharmaceutical composition for use in preventing or treating BET protein related diseases containing the same as an active ingredient | 20170126 |
KR-20180089298-A | Novel [1,2,4]Triazolo[4,3-a]quinoxaline derivatives, preparation method therof, and pharmaceutical composition for use in preventing or treating BET protein related diseases containing the same as an active ingredient | 20170126 |
Complexity: | 233 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 208.9992041 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 208.9992041 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 71.6 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.1 |
-
Catalog: BB044022
Tris(2-fluorophenyl)phosphane
Detail
-
Catalog: BB044023
2-Anthracenecarboxylic acid, 9,10-bis[[[(2-boronophenyl)methyl]methylamino]methyl]-
Detail
-
Catalog: BB044017
2-(methoxycarbonyl)benzenediazonium tetrafluoroborate
Detail
-
Catalog: BB003758
1,2,3-Triphenylbenzene
Detail
-
Catalog: BB008128
1-chloro-7-(trifluoromethyl)phthalazine
Detail
-
Catalog: BB008250
4-(methylamino)-1,2-dihydrophthalazin-1-one
Detail
-
Catalog: BB007529
11-bromo-1,8,10-triazatricyclo[7.4.0.0²,⁷]trideca-2(7),3,5,8,10,12-hexaene
Detail
-
Catalog: BB054380
Benzo[ghi]perylene
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Arenes
Customers Also Viewed
-
[44994-28-7]
N,N,N',N'-Tetramethyl-1,5-pentanediamine
-
[72607-53-5]
N-(3-Aminopropyl)methacrylamide Hydrochloride
-
[14245-62-6]
Isopropyl ethanesulfonate
-
[79551-14-7]
Ferene Disodium Salt
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[891016-02-7]
ML-SI3
INDUSTRY LEADERS TRUST OUR PRODUCTS